Salamanca, Spain
The Precision-BTC-Network is gearing up for what will be its final annual meeting!
Along with ENS-CCA, we are excited to once again bring together experts and stakeholders from across the BTC community for two days of insightful exchange and excellent collaboration, this year around the important theme of Addressing Orphan Aspects in Biliary Tract Tumours.
The aim of this event is to reflect on current challenges we are facing when managing patients diagnosed with BTC, taking a particular focus on orphan aspects that are usually not touched upon.
Registration and a preliminary agenda will be available shortly.
We look forward to seeing you in Salamanca in April 2027!
Jagiellonian University, Didactic Centre of the Faculty of Law and Administration
Krakow, Poland
The annual meeting of the COST Action PRECISION-BTC-NETWORK (Management Committee and General Meeting) was held jointly with the biennial ENS-CCA conference.
This meeting focused on biliary tract cancer, covering a wide range of topics including adjuvant treatment, immunotherapy, biomarkers for patients’ selection, the role of artificial intelligence in guiding treatment choice, discussion of the data from the large international European registry on bile duct cancers, and the development of novel therapeutics with a focus on targeting the microenvironment and the immune system.
Hotel Palma Bellver
Mallorca, Spain
The Monothematic Conference Liquid Biopsy in BTC: from bench to bedside was held jointly with the annual meeting of the COST Action Precision-BTC Network (Management Committee and General Meeting). This meeting focused on biliary tract cancer, with a major aim to consolidate current knowledge and to draw a roadmap towards the adoption of liquid biopsy as a key tool in the diagnosis and personalized treatment of biliary tumors. Additionally, the conference hosted discussions on the latest findings related to epidemiology, new therapies, artificial intelligence and preclinical models for the development of new drugs for patients with biliary tumors.





Rodos Palace Hotel
Rhodes, Greece
The ENS-CCA/Precision BTC Network Joint Conference has been sponsored by pharmaceutical companies through the purchase of sponsorship packages which include exhibition spaces and/or advertisements. They have had no involvement or input in the arrangement, content or agenda of the meeting. a full list is available on the conference webpage (https://precision-btc.eu/events/actionmeetings) and within the congress app under the ‘Supporters/Sponsors’ tab.
The annual meeting of the COST Action PRECISION-BTC-NETWORK — held jointly with the biennial ENS-CCA conference — delivered on a dynamic and forward-looking program focused on advancing the field of biliary tract cancers and fostering high-impact collaborations.
The first day of this two day event were dedicated to Academia–Pharma interaction — a space to strengthen partnerships, share insights, and explore translational opportunities.
The second day was focused on collaborative projects from our diverse Working Groups — showcasing the power of teamwork across borders and disciplines.





Online
The annual meeting of the Precision-BTC-Network's Management Committee to discuss the present state and future direction of the Action. This year's meeting will be held entirely online via video call.
Stansted, United Kingdom
The theme for this year's conference is: 'Cholangiocarcinoma: A Fairer Deal, Faster – RETHINKING LIVER CANCER'.
The conference will focus on tackling health inequalities in cholangiocarcinoma diagnosis and treatment, building on insights from AMMF’s data project. An international faculty of some 40 speakers will discuss key challenges in earlier diagnosis, multi-disciplinary assessments, and specialist referrals, all of which influence patient outcomes.
Click the links below for a recording of this conference & for more information!
Stansted, United Kingdom
AMMF’s annual conference is a unique and invaluable educational opportunity for all healthcare professionals and researchers with an interest in cholangiocarcinoma. As always, 2026 will include dedicated sessions for patients, carers, families and friends, too.
Each year, AMMF aims to deliver a world-leading event – and 2026 is no exception. For this conference, the multi-disciplinary specialist group Cholangiocarcinoma-UK* is partnering with AMMF to highlight the latest progress in the rapidly evolving treatment landscape for cholangiocarcinoma.
AMMF is delighted to have international co-chairs Professor Brian Davidson (UK) and Dr Angela Lamarca (Spain; Precision-BTC-Network WG3 co-Leader/Management Committee) to lead a distinguished global faculty, as together they explore the 2026 theme, Shaping the future: from early detection to improved survival.
Salt Lake City, Utah
The event is a unique opportunity for patients and caregivers to join leading experts in shaping the future of cholangiocarcinoma research. The initiative brings together patients, caregivers, advocates, oncologists, scientists, industry representatives, regulators, and other specialists worldwide to review scientific evidence, share insights, and reach a consensus on the research focus going forward to optimize existing funding and attract new funding.
This year’s Conference is an effort between CCF’s International Cholangiocarcinoma Research Network (ICRN) and the European Cooperation in Science and Technology (COST)-Action: Precision-BTC-Network.
Salt Lake City, Utah
The 13th Annual Cholangiocarcinoma Foundation Conference convenes leading researchers, clinicians, patients, caregivers, and advocates to explore the latest advancements in cholangiocarcinoma and foster collaboration across the community. This year’s conference also celebrates CCF’s 20th anniversary, making it a particularly special gathering.
Conference Chairs: Luke Boulter (Boulter-Lab, University of Edinburgh; Precision-BTC-Network WG6 co-Leader/Management Committee) & Tim F. Greten (Co-Director, NCI CCR Liver Cancer Program)